Question 1

Does Ubs own AVTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 1,209,059 shares of AVTX (Avalo Therapeutics), worth $22.3M.

Question 2

How many shares of AVTX does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 1,209,059 shares of AVTX (Avalo Therapeutics).

Question 3

What is Ubs' AVTX position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' AVTX position is worth $22.3M.

Question 4

Is Ubs buying or selling AVTX?

Accepted Answer

In Q2 2026, Ubs increased its AVTX position by 67,079 shares (+5.9%).

Question 5

When did Ubs first buy AVTX?

Accepted Answer

Ubs first reported AVTX in its Q4 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.2M	+5.9%	$22.3M	0.0%	$18.48	30
2026-Q1	Increased	1.1M	+139.0%	$17M	0.0%	$18.85	46
2025-Q4	Increased	477,816	+956.9%	$8.7M	0.0%	$17.81	44
2025-Q3	Decreased	45,208	-46.0%	$574,594	0.0%	$13.02	0
2025-Q2	Decreased	83,724	-15.4%	$417,783	0.0%	$4.78	0
2025-Q1	Increased	98,951	+0.4%	$792,598	0.0%	$8.46	25
2024-Q4	Increased	98,519	+1506.1%	$731,996	0.0%	$7.80	40
2024-Q3	Increased	6,134	+71.2%	$58,273	0.0%	$9.40	21

AVTXShowing 8 of 11 quarters

AVTX
Showing 8 of 11 quarters